No, retatrutide isn't on the NHS as of 2026. We explain when it might be, who'll be eligible, and the MHRA-approved alternatives available now.

You can only get Saxenda on the NHS via a tier 3 weight management service. Find out more about eligibility and other options here.

Wegovy is available on the NHS only through specialist weight-management services, for a BMI of 35+ with a weight-related condition. See how to apply.

Mounjaro and Wegovy are available on the NHS for those who are eligible. Mounjaro is prescribed by GPs in a phased rollout; Wegovy via specialist services.

Mounjaro is on the NHS for type 2 diabetes and, via a phased rollout, for some people with obesity. See the 2026 eligibility criteria and costs.

Mounjaro and Wegovy average 15–21% weight loss, but results vary widely. Here's what the average can and can't tell you about your own weight loss outcomes.

You can travel with Wegovy by air. Keep the injection cool in your hand luggage, carry your prescription, and pack the pill like any other tablet.

You can stay on Wegovy long-term if it's medically appropriate. Most reach their goal in 14-18 months, then continue, step down, or transition off.

You can take Wegovy with levothyroxine as research suggests the combination doesn't interfere with the drug's effects or safety profiles. Find out more.

Wegovy vs Mounjaro: compare average weight loss, side effects and UK cost, plus the new 7.2 mg dose and Wegovy pill, to find which injection suits you.